Haemorrhagic shock may progress under certain circumstances by the events described in the diagram shown in Figure lining and adjacent to a closed capillary become slightly anoxic, they secrete histamine which causes the capillary to open. The histamine is destroyed in the blood quickly and does not circulate. When the mast cells are satisfied, they halt histamine secretion and the capillary closes. In this way the capillaries take turns in being perfused. Capillary flow is rapid and the fall in pH alongthecapillaryissmall, perhaps from 7-4 to 7.3. Lactic acid is continuously being excreted in minimal amounts by the cells and carried away by the capillary flow; normally this is so good that lactic acid does not accumulate. The sequence of events in haemorrhagic shock is as follows.
Phase I: Reversible Haemorrhagic Shock STAGE 1: VASOCONSTRICTION Initiated by some shock-producing stress such as a haemorrhage or trauma, the sudden secretion of catecholamines and the high blood levels of these emergency hormones initiate an intense arteriolar vasoconstriction. This stage is that of compensated or partially compensated shock and blood pressure may be normal. However, the pulse may be rapid and thready. There is other evidence of sympathetic stimulation: pale, sweaty skin, rapid, thready pulse, elevation in blood glucose, and general nervousness. These are common clinical findings associated with shock. The catecholamine level in the blood remains high throughout shock, even until death. The significance of coagulative and thrombotic changes after haemorrhage and injury mucosa. Those who rely on measurements of blood loss to gauge volume replacement are often fooled by this phenomenon. A frequent comment is that more blood was lost than is realized. This capillary and venule expansion has two important effects on the shock picture. First, the vascular space is greatly expanded. This makes even a normal blood volume inadequate to fill it. The capillary and venule capacity is so great that very little blood is left over to reach the great veins and venae cavae. Vena caval pressure falls to zero, resulting in a great reduction of venous return to the right atrium. Then the cardiac output falls still further, and also arterial pressure. Second, the low blood pressure, extremely constricted arterioles, open arteriovenous shunts, and many open capillaries together produce an extremely stagnant capillary flow. This causes slow delivery of oxygen and increased anoxic metabolism. With increased secretion of lactic acid into the slow-moving capillary blood, the blood becomes acidic by the time it reaches the venous end of the capillary. A marked lactic-acidaemia develops quickly, first in the venous blood and later also in the arterial blood. The body compensates for the acidaemia by blowing off CO2 till the excess lactate is eventually removed. In fact, in early shock this I. compensatory mechanism may even overcompensate and produce a respiratory alkalosis. However, compensation becomes inadequate as the lactic acid level continues to increase and the pH falls, producing a true acidosis. This acidosis has a number of effects, including a marked effect on blood coagulability. Its full extent will not be realized if one merely takes the pH of arterial blood, because it is in the veins where it is most prominent. In addition, certain vascular beds will be much more affected, that is, where vasoconstriction is worst as in the abdominal viscera. Blood pH levels as low as 6.6 have been recorded here. Further, arteriovenous shunting may help to raise the venous pH. This may give a false sense of security. Capillary and tissuepH is probably much lower. Very important is the tremendous increase in lactic acid which must occur around cells which aredeniedperfusion. Anaerobicmetabolism, which soon comes on, increases this. Delicate cellular enzymes cannot work under these conditions.
The effect of this acidosis on blood coagulation is dramatic. (Fig. 1) (Figs. 4, 5, 6) or cause cells to stick together into small thrombi. The thrombi occlude the first capillary or small vessel they come to. Or they may form in situ in a small vessel (Fig. 7) . Capillary coagulation may completely halt local perfusion, cutting off all nutrition and stopping the removal of acid cellular metabolites. These increase around the cells quickly creating such a marked local acidosis that the pH falls to levels. incompatible with cell enzyme activity; metabolism soon stops and the cells die. Prothrombin time and partial thromboplastin time become prolonged. Platelets decline markedly. This sudden onset of incoagulability denotes the onset of disseminated intravascular coagulation and, therefore, is a sign of a very poor prognosis. Death of dogs which exhibit a prolonged silicone clotting time is almost certain (Fig. 2) The significance of coagulative and thrombotic changes after haemorrhage and injury and progresses. The determination of blood enzyme levels such as LDH, SGOT, and SGPT may be an index of the onset and progress of tissue necrosis. Death of the whole organism may ensue when cell death in vital organs is sufficient to be incompatible with function. The amount of necrosis required for organ failure will vary with the original health of the organ. As much as three-quarters ofnormal kidneys may be destroyed with adequate function; but if kidneys are already diseased, death of only a small number of cells will be enough to produce renal failure. The same principle applies to other organs. However, under proper conditions of supportive treatment (such as an artificial kidney) the remaining living cells (kidney or liver) may multiply and reconstitute an adequate amount of parenchyma to produce adequate organ function; the organism may then survive.
If capillaries remain occluded for an hour or so, the cells nourished undergo changes which rapidly become irreversible. Lack of oxygen results in anaerobic metabolism with increased lactic-acid production; lack of perfusion increases acid metabolites, and cellular enzymes cannot function at a low pH. It becomes impossible to maintain differentials across the cell membrane: potassium then leaves the cell and sodium enters it. The cells become unable to metabolize raw materials and metabolism stops. Soon, certain changes can 114 be noted by electron microscopy, first affecting mitochondria, and later focal necrosis in certain areas can be noted by light microscopy. Large areas of necrosis can be tolerated in many organs without death of the whole organism, but if enough tissue dies in certain vital organs, that organ fails. Hepatic failure is perhaps most common and the earliest in onset (Fig. 8) . It is heralded by a dramatic fall in the blood glucose level, which up to this time has been high due to the effect of catecholamine secretion. Failure of the kidneys is evidenced by persistent anuria; up to this time, urine flow has been reduced or only transiently halted. There may be evidence of heart failure with a rising central venous pressure even without volume administration (Fig. 9) . Gastrointestinal necrosis may be denoted by the onset of melaena. Focal areas of necrosis in the pancreas may liberate trypsin which, if it gainsaccesstothe blood stream, results in further clotting. Lung tissue does not usually become necrotic, perhaps because of the availability of oxygen and the relatively low metabolic requirements of its connective tissue and endothelium. However, thrombosis may produce a severe picture of haemorrhage into alveoli leading to death from respiratory failure. The picture is that ofhaemorrhagic infarction. Death of the organism may follow from any or all of these organ failures.
A review of the cases of the 'crush syndrome' in Fig. 9 Microinfarct of the myocardium. Patient Bywaters (1942) noted that haemorrhage could be either internal or external and was the most common complication of this syndrome.
The mechanism of this haemorrhagic diathesis was not then known. Because of the similarity of this syndrome to the incompatible transfusion syndrome, the possibility arose that the haemorrhagic phenomena in both might be due to the same mechanism. (Fig. 10) . One hundred blows to one thigh resulted in a moderately swollen and discoloured tbigh which was not at all disabling two days later. It was not certain whether the pigment was haemoglobin or myoglobin, but it was surprising that its excretion increased over a two-day period in the face of normal renal output. The effects of an equivalent amount of haemolysis without any trauma were then investigated. The haemoglobinaemia produced after 48 hours could be roughly duplicated by removing 20 ml of the animal's blood, freezing it, thawing it, and returning it to the animal. This amount of haemolysis had no demonstrable effect alone. In fact, the administration of 100 ml of autogenous haemolysed blood was also without obvious effect. However, other experiments proved that even the 20 ml dose was capable of producing dramatic effects. The following observations were made on dogs suffering from haemorrhagic shock (Fig. 11). 1 A small amount (20 ml) of haemolysed blood, given before haemorrhagic shock is produced, causes an increase in mortality of dogs from 13 % to 91%.
2 This lethal effect is due to the stimulation by haemolysed blood of intravascular coagulation. However, in normal rapid capillary flow, coagulation does not take place. A second factor is necessary, namely, stagnant capillary flow as produced by arterial hypotension, arteriolar vasoconstriction, and capillary dilatation. All of these are produced by an otherwise non-lethal haemorrhage.
3 The lethal factor of haemolysed blood is a clotting factor (thromboplastin) in red cells.
4 Large amounts (100 ml) of haemolysed blood alone are harmless, but even a small amount (20 ml) is lethal in the presence of shock.
5 Haemolysed blood causes the conversion of fibrinogen to fibrin.
6 Therapeutic 'fibrinolysin' will prevent death in otherwise irreversible haemorrhagic shock either produced by haemorrhage alone or when influenced by haemolysed blood.
7 Endogenous heparin secretion is stimulated by disseminated intravascular coagulation produced either by haemorrhage alone, haemolysed blood alone, or by a combination. It is probably a protective mechanism.
8 A markedly prolonged silicone clotting time occurring during haemorrhagic shock is an accurate prognostic index of irreversibility.
9 Irreversibility is correlated with a fall in the plasma fibrinogen level when that is due to consunmption in disseminated intravascular coagulation.
Red cells contain a thromboplastin which initiates blood coagulation. Hom e-er, fairly largescale haemolysis is harmless in a normal circulation; intravenous injection of distilled water is harmless to normal humans, and the only effects are transient haemoglobinaemia and haemoglobinuria. Injection of 100 ml ofautogenous haemolysed blood into normal animals produced no harmful results but it did produce a transient, but dramatic, prolongation in silicone clotting time, a transient rise in prothrombin time, a transient rise in endogenous heparin, and a mild and transient fall in the fibrinogen level. All returned to normal within four hours. However, when combined with otherwise non-fatal haemorrhagic shock, even 20 ml ofautogenous haemolysed blood was fatal in over 90 % of animals. It also produced a significant increase in fibrinogen utilization, and increased clotting and prothrombin times. The effects were progressive over the four-hour shock period. The fatal effect of haemolysed blood is attributed to initiation of an episode of disseminated intravascular coagulation. It was not produced by an injection of pure haemoglobin. It is postulated that the shock-induced stagnant The significance of coagulative and thrombotic changes after haemorrhage and injury capillary circulation, plus the initiation of coagulation by haemolysis, caused clotting of the blood in the microcirculation, and that haemolysis initiates coagulation by the liberation of red-cell thromboplastin. That the toxic effects of haemolysed blood are due to its stimulation of disseminated intravascular coagulation is supported by the protective effect of fibrinolysin. Fibrinolysin administered during haemorrhagic shock after the administration of 20 ml of autogenous haemolysed blood reduced the mortality from 91 to 38%. Fibrinolysin acts by lysing capillary thrombi.
Clinical Studies
Twenty-nine patients in refractory shock were studied at the Walter Reed shock unit. All developed a coagulation defect (Figs. 12-15) . Table I is a summary of the results. It was not possible to associate clearly a coagulation abnormality with the shock syndrome in every case, because of preexisting diseases and/or therapeutic agents administered before the onset of shock.
In 22 patients, the coagulation abnormality was definitely associated with the shock syndrome and no other aetiology was possible. Five had severe infection, four giving positive blood cultures. Bacteraemia was suspected in the other but blood culture was negative probably because of antibiotic therapy.
Coagulation studies were carried out on 130 cases of shock at the Third Surgical Hospital in Vietnam. The general character of these patients was different from those at Walter Reed. The Vietnam cases generally had severe oligaemic shock from battle wounds. However, most were easily restored to a normal condition by transfusion and only a few could be regarded as 'refractory' shock, unlike nearly all the cases studied at the Walter Reed Hospital.
Sixty of the 130 cases had coagulation abnormalities. In general, these were of two types, hypercoagulability and hypocoagulability. Evidence of hypercoagulability was found in 14 subjects with prothrombin times less than 11 seconds or partial thromboplastin times below 30 seconds (Fig. 12) . This may be analogous to the hypercoagulable phase of haemorrhagic shock in dogs discussed earlier (Fig. 2) three factors, 'shock', extensive transfusion (more than 10 units of blood in the first 24 hours), and embolization (unexplained preoperative hypoxaemia), was rare in the absence of the other two and no apparent association with a clotting defect was seen in these few patients (Table II ). All combinations which included 'shock', however, were associated with a clotting defect.
No pattern of change associated with rapid transfusion emerged in this series: six normotensive patients given 6 to 15 units of blood rapidly had normal clotting studies at all times. Figure 13 illustrates a shortening of clotting times during rapid transfusion from initially prolonged values, with subsequent prolongation several hours after cessation of transfusion. This kind of response is seen during temporary replacement of depleted clotting factors by transfused blood or blood products. The pattern is not that expected if bank blood were responsible for the bleeding problems often attributed to its use. Shortening of clotting times during rapid transfusion with later prolongation was seen in eight patients.
The more expected change, a lengthening of clotting times with rapid transfusion, was seen in six patients, but the clotting times decreased as transfusion was continued.
Finally, no definite pattern of change in fibrinogen levels could be detected. Any changes were relatively small in the acute phase. Of course all the patients were transfused with blood with normal fibrinogen levels. Fibrinogen levels often rose to about 1,000 mg per 100 ml on the second or third day after injury, especially in those with high velocity missile injuries. At this time the prothrombin and partial thromboplastin times were usually below normal.
In spite of the uncontrolled nature and multiplicity of the variables in this study, several conclusions seem warranted. Severely injured combat casualties often exhibit clotting abnormalities during the acute phase of injury. Thisappeared to be associated with extensive tissue damage, extensive transfusion of stored blood, presumed embolization at the time of injury, and haemorrhagic hypotension. Of all the factors, hypotension seems the most important. Combinations of factors, especially with prolonged hypotension, increased the likelihood of a clotting defect. Neither the aetiology nor the clinical significance of the clotting changes was apparent in this study except for an association with severely injured patients. Extremely abnormal clotting values were seen only in the few who died. Clinical bleeding problems were rare, but when they occurred it is not justifiable to attribute them to clotting aberrations due to replacement of the patient's blood with bank blood. Hypoperfusion appeared to be more important in our clinical study and also experimentally.
Most patients studied received stored bank blood for the treatment of oligaemia and during surgery. It is known to differ from normal circulating blood in many ways. In contrast to the situation in large civilian hospitals, the blood used in a field medical unit in a combat zone necessarily travels long distances, and usually undergoes several short periods with little or no refrigeration. Generator failures, especially during the monsoon season, are expected occurrences and are accompanied by unavoidable variations in blood-bank-refrigerator temperatures. For these reasons it was of interest to estimate the clotting properties of the bank blood at its point of usage. Blood was drawn from the intravenous tubing during the latter half of a transfusion and handled exactly as for arterial samples except that additional citrate was not added for the clotting studies. All the blood studied was in Fenwal plastic bags said to contain 450 ml blood plus 67-5 ml NIH solution A. All the units of blood were administered through disposable field-type blood recipient sets (Fenwal or Burron).
The results are summarized in Table VII . Bank blood, even old bank blood, has a relatively normal coagulation profile. In most cases it should not contribute to a coagulation defect, but should actually help to correct it. On the basis of our studies, one conclusion can be surely drawn: definite changes in the blood clotting values of these young, acutely injured adults who require blood replacement, cannot be attributed simply to the use of bank blood.
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Summary
Severe or refractory shock due to trauma, infection, or other cause is usually associated with an episode of disseminated intravascular coagulation as manifested by the rapid development of a consumptive coagulopathy, and the finding of multiple intravascular thrombi associated with areas of focal necrosis in various vital organs.
